BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8589208)

  • 1. Thrombin inhibition in the acute phase of ischaemic stroke using argatroban.
    Kario K; Kodama K; Koide M; Matsuo T
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):423-7. PubMed ID: 8589208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.
    LaMonte MP; Nash ML; Wang DZ; Woolfenden AR; Schultz J; Hursting MJ; Brown PM;
    Stroke; 2004 Jul; 35(7):1677-82. PubMed ID: 15155959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis.
    Kobayashi S; Tazaki Y
    Semin Thromb Hemost; 1997; 23(6):531-4. PubMed ID: 9469625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
    Oguro H; Mitaki S; Takayoshi H; Abe S; Onoda K; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2175-2181. PubMed ID: 29706441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
    Matsuo T; Koide M; Kario K
    Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Barreto AD; Ford GA; Shen L; Pedroza C; Tyson J; Cai C; Rahbar MH; Grotta JC;
    Stroke; 2017 Jun; 48(6):1608-1616. PubMed ID: 28507269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.
    Urabe T; Tanaka R; Noda K; Mizuno Y
    J Thromb Thrombolysis; 2002 Jun; 13(3):155-60. PubMed ID: 12355032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.
    Wada T; Yasunaga H; Horiguchi H; Matsubara T; Fushimi K; Nakajima S; Yahagi N
    Stroke; 2016 Feb; 47(2):471-6. PubMed ID: 26670085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
    Guy S; Kitchen S; Maclean R; Van Veen JJ
    Int J Lab Hematol; 2015 Dec; 37(6):834-43. PubMed ID: 26305560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban in thrombotic stroke.
    LaMonte MP
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():39-45. PubMed ID: 12811011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban inhibits intraocular fibrin formation after vitrectomy in rabbits.
    Maeno T; Tano Y; Mano T; Takenaka H
    Arch Ophthalmol; 2000 Oct; 118(10):1401-5. PubMed ID: 11030823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of argatroban.
    Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
    Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of argatroban surrounding a lumbar puncture: a case report.
    Faust AC; Oliphant CS
    Am J Hematol; 2011 Aug; 86(8):720. PubMed ID: 21761442
    [No Abstract]   [Full Text] [Related]  

  • 19. Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
    Liu S; Liu P; Wang P; Zhang F; Wang L; Wang Y; Lu H; Ma X
    Med Sci Monit; 2020 Jul; 26():e924593. PubMed ID: 32667287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.